114 related articles for article (PubMed ID: 16899458)
1. Significance of ectodomain cysteine boxes 2 and 3 for the activation mechanism of the thyroid-stimulating hormone receptor.
Mueller S; Kleinau G; Jaeschke H; Neumann S; Krause G; Paschke R
J Biol Chem; 2006 Oct; 281(42):31638-46. PubMed ID: 16899458
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface.
Kleinau G; Jäschke H; Neumann S; Lättig J; Paschke R; Krause G
J Biol Chem; 2004 Dec; 279(49):51590-600. PubMed ID: 15345720
[TBL] [Abstract][Full Text] [Related]
3. Contacts between extracellular loop two and transmembrane helix six determine basal activity of the thyroid-stimulating hormone receptor.
Kleinau G; Claus M; Jaeschke H; Mueller S; Neumann S; Paschke R; Krause G
J Biol Chem; 2007 Jan; 282(1):518-25. PubMed ID: 17079233
[TBL] [Abstract][Full Text] [Related]
4. Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation.
Mueller S; Kleinau G; Jaeschke H; Paschke R; Krause G
J Biol Chem; 2008 Jun; 283(26):18048-55. PubMed ID: 18441013
[TBL] [Abstract][Full Text] [Related]
5. Cysteine 390 mutation of the TSH receptor modulates its ectodomain as an inverse agonist on the serpentine domain with decrease in basal constitutive activity.
Ho SC; Goh SS; Su Q; Khoo DH
Mol Cell Endocrinol; 2005 Dec; 245(1-2):158-68. PubMed ID: 16364538
[TBL] [Abstract][Full Text] [Related]
6. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
Han SJ; Hamdan FF; Kim SK; Jacobson KA; Bloodworth LM; Li B; Wess J
J Biol Chem; 2005 Oct; 280(41):34849-58. PubMed ID: 16093246
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
Neumann S; Claus M; Paschke R
Eur J Endocrinol; 2005 Apr; 152(4):625-34. PubMed ID: 15817920
[TBL] [Abstract][Full Text] [Related]
8. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity.
Ho SC; Van Sande J; Lefort A; Vassart G; Costagliola S
Endocrinology; 2001 Jul; 142(7):2760-7. PubMed ID: 11415994
[TBL] [Abstract][Full Text] [Related]
9. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
[TBL] [Abstract][Full Text] [Related]
10. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
[TBL] [Abstract][Full Text] [Related]
11. Differential responses of an invariant region in the ectodomain of three glycoprotein hormone receptors to mutagenesis and assay conditions.
Angelova K; Puett D
Endocrine; 2002 Nov; 19(2):147-54. PubMed ID: 12588044
[TBL] [Abstract][Full Text] [Related]
12. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation.
Neumann S; Krause G; Chey S; Paschke R
Mol Endocrinol; 2001 Aug; 15(8):1294-305. PubMed ID: 11463854
[TBL] [Abstract][Full Text] [Related]
13. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit.
Chazenbalk GD; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2004 Apr; 89(4):1788-93. PubMed ID: 15070946
[TBL] [Abstract][Full Text] [Related]
14. Role of cleavage and shedding in human thyrotropin receptor function and trafficking.
Quellari M; Desroches A; Beau I; Beaudeux E; Misrahi M
Eur J Biochem; 2003 Sep; 270(17):3486-97. PubMed ID: 12919313
[TBL] [Abstract][Full Text] [Related]
15. An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function.
Jaeschke H; Neumann S; Kleinau G; Mueller S; Claus M; Krause G; Paschke R
Endocrinology; 2006 Apr; 147(4):1753-60. PubMed ID: 16410307
[TBL] [Abstract][Full Text] [Related]
16. Specific activation of the thyrotropin receptor by trypsin.
Van Sande J; Massart C; Costagliola S; Allgeier A; Cetani F; Vassart G; Dumont JE
Mol Cell Endocrinol; 1996 May; 119(2):161-8. PubMed ID: 8807635
[TBL] [Abstract][Full Text] [Related]
17. The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH.
Jaeschke H; Schaarschmidt J; Günther R; Mueller S
Endocrinology; 2011 Oct; 152(10):3986-96. PubMed ID: 21846801
[TBL] [Abstract][Full Text] [Related]
18. Paired cysteine mutagenesis to establish the pattern of disulfide bonds in the functional intact secretin receptor.
Lisenbee CS; Dong M; Miller LJ
J Biol Chem; 2005 Apr; 280(13):12330-8. PubMed ID: 15664984
[TBL] [Abstract][Full Text] [Related]
19. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity.
Chen CR; Chazenbalk GD; McLachlan SM; Rapoport B
Endocrinology; 2003 Sep; 144(9):3821-7. PubMed ID: 12933653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
